The United Nations Office on Drugs and Crime (UNODC) is leading a coordinated global response to improve the access to and availability of controlled drugs for medical purposes, particularly for the management of pain. The aim is to increase the number of patients receiving appropriate treatment for conditions requiring the use of specific medication, while controlling the diversion and non-medical use of those substances.
This Joint Global Programme on "Access to Controlled Drugs for Medical Purposes While Preventing Diversion and Abuse" (also known as GLOK67) is the result of the cooperation between UNODC, the World Health Organization (WHO) and the Union for International Cancer Control (UICC).
Areas of focuses for this work:
UNODC helps Member States to address major impediments that contribute to the underuse of controlled medicines.
The International Narcotics Control Board (INCB), the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) call on governments to ensure that the procurement and supply of controlled medicines in countries meet the needs of patients, both those who have COVID-19 and those who require internationally controlled medicines for other medical conditions.
This section is designed to provide the public and individuals with general and basic information about the Joint Global Programme and highlights the content of the Discussion Paper and the Reports issued by UNODC, WHO, UICC and the INCB.
The United Nations Office for Drugs and Crime works actively on the Joint Global Programme, GLOK67. In this section, we describe our work, recommendations for Member states and next steps, together with the publications on this matter.
Healthcare professionals and Ministries of Health in focus countries are the direct beneficiaries of the Global Programme. UNODC, the WHO, UICC and the International Narcotics Control Board (INCB) provide recommendations and tools to help healthcare personnel in improving accessibility and availability and at the same time preventing diversion and abuse.
Policy-makers are vital in ensuring the availability and access to controlled medications as they design, oversee implementation and monitor policies and regulations. With policy-makers involvement, countries can overcome barriers to the accessibility and availability of controlled drugs. UNODC, WHO, UICC and INCB have additional information to facilitate the work of policy-maker.
The Joint Global Programme, GLOK67 is one of the programmes in which the Prevention, Treatment and Rehabilitation Section of the Drugs and Health Branch within UNODC currently works on. In this webpage you can access publications issued by the UNODC in regard to the accessibility and availability of controlled drugs.
